Newstral
Article
Forbes on 2021-05-06 01:51
InnovationRx: Biden’s Pharma Patent Fight; Plus Universal Covid Vaccines
Related news
How Big Pharma share prices tumbled after Joe Biden’s vaccine patent waiverNew Statesman
InnovationRx: Making The Pharma Supply Chain More ResilientForbes
Biden’s Vaccine Patent Theftwsj.com
Will a Patent Waiver for Covid Vaccines End the Pandemic?slate.com
America wants to waive patent protection for vaccinesThe Economist
InnovationRx: FTC Investigating Cerebral; Plus, FDA Panel OKs Vaccines For Young KidsForbes
InnovationRx: Artificial Intelligence 50; Plus Covid Treatments In IndiaForbes
Big Pharma CEOs Profited Millions From COVID-19 Vaccines—Except For Oneobserver.com
Will Joe Biden’s support for Covid-19 patent waivers inoculate the world?New Statesman
‘Gamechanger’: US backs COVID vaccines patent waiverSydney Morning Herald
- FPharma industry fears Biden’s patent move sets dangerous precedentft.com
EDITORIAL: Vaccines, lockdowns and Biden’s virus committeereviewjournal.com
InnovationRx: Telemedicine’s Back-End; Plus Mask ConfusionForbes
- MPoor nations don't need patent waivers to obtain enough COVID vaccines to achieve herd immunity, they just need $4 billionmarketwatch.com
Canada supports review of patent protections for COVID-19 vaccinesthestar.com
Democrats bankrolled by Big Pharma are refusing to back COVID vaccine patent waiveralternet.org
Biden’s vaccine-patent gambit turns up the heat on drugmakersThe Japan Times
WTO Agrees to Partial Patent Waiver for COVID-19 Vaccinesjdsupra.com
The World Desperately Needs Vaccines, Not Patent RightsForbes
European Parliament backs patent waiver for coronavirus vaccinesPolitico.eu